Gisele

September's Top 10 Celebrity Real Estate News: Gisele Bündchen, Jessica Simpson & Howard Hughes

Retrieved on: 
Thursday, September 28, 2023
HBO, Aviation, Hughes, Gisele, The Brady Bunch, United States drug overdose death rates and totals over time, CBS, Sale, Silver, Hancock Park, Water, Tamposi, Great Neck Estates, New York, The Mary Tyler Moore Show, McDowell, Aviator, News, Real estate, Hotel, Film industry

POMPANO BEACH, Fla., Sept. 28, 2023 /PRNewswire-PRWeb/ -- September's Top 10 Celebrity Real Estate News

Key Points: 
  • Gisele Bündchen, Jessica Simpson & Howard Hughes made real estate news in September.
  • Top 10 Celebrity Real Estate News is featured at TopTenRealEstateDeals.com.
  • Gisele Bündchen is the new owner of a 7.5-acre equestrian ranch in Southwest Ranches, Florida.
  • Howard Hughes was a brilliant entrepreneur whose interests included aviation, film production, and real estate.

Awin and ShareASale Appoint Gisele Mast as Chief Product & Technology Officer

Retrieved on: 
Tuesday, March 21, 2023
Heart, Chief technology officer, Awin language, Booking.com, Shareasale, B2B, Marketing, Priceline.com, Gisele, Integrative Production Technology for High-Wage Countries, Kiwi.com, Tripadvisor, Growth, Pharmaceutical industry, Management, Martech

BALTIMORE, March 21, 2023 /PRNewswire-PRWeb/ -- Awin and ShareASale today announced they have appointed Gisele Mast as the Awin Group's Chief Product and Technology Officer.

Key Points: 
  • BALTIMORE, March 21, 2023 /PRNewswire-PRWeb/ -- Awin and ShareASale today announced they have appointed Gisele Mast as the Awin Group's Chief Product and Technology Officer.
  • Gisele joins the Awin Group with a wealth of industry experience, having most recently served as the Chief Product Officer at Kiwi.com.
  • Gisele joins the Awin Group's Executive Board alongside Chief Executive Officer Adam Ross, Chief Financial Officer Virpy Richter, and Chief Customer Officer David Lloyd.
  • She succeeds Chief Technology Officer Peter Loveday, who left the company in December 2022.

Inhibikase Therapeutics Appoints Gisele Dion to Board of Directors

Retrieved on: 
Thursday, September 1, 2022
Therapy, RAMP, Information system, Form 10-K, Takeda Pharmaceutical Company, Regulation, Biogen, Market for corporate control, NASDAQ, Brain, Gisele, YouTube, Pharmacy, Protein, Risk, Compensation, Hope, Disclosure, Multiple system atrophy, Board, Pharmaceutical Research and Manufacturers of America, Audit committee, LinkedIn, Senior, Parkinson's disease, Management information system, SEC, GI, Imatinib, Fairfield University, CFO, Regulation Fair Disclosure, Retirement, Board of directors, Company, Neurodegeneration, Compliance, Twitter, Mesylate, Shire (pharmaceutical company), GAAP, Annual report, Director, Private Securities Litigation Reform Act, Patient, Professional Football Compensation Committee, Pharmaceutical industry, Management, Accounting, Takeda, Facebook

BOSTON and ATLANTA, Sept. 1, 2022 /PRNewswire/ --Inhibikase Therapeutics, Inc. (NASDAQ: IKT) (Inhibikase), a clinical-stage pharmaceutical company developing therapeutics to modify the course of Parkinson's disease and related disorders as well as other diseases arising from protein kinases, today announced the appointment of Ms. Gisele Dion to its Board of Directors, effective September 1, 2022.

Key Points: 
  • BOSTON and ATLANTA, Sept. 1, 2022 /PRNewswire/ --Inhibikase Therapeutics, Inc. (NASDAQ: IKT) (Inhibikase), a clinical-stage pharmaceutical company developing therapeutics to modify the course of Parkinson's disease and related disorders as well as other diseases arising from protein kinases, today announced the appointment of Ms. Gisele Dion to its Board of Directors, effective September 1, 2022.
  • "I am excited to have Gisele join the Board of Inhibikase.
  • In addition, on behalf of the entire Board of Directors, I want to thank Liz for her service and contributions to Inhibikase over the last three and a half years."
  • Inhibikase Therapeutics, Inc. (NASDAQ: IKT) is a clinical-stage pharmaceutical company developing therapeutics for Parkinson's disease and related disorders.

FTX, Tom Brady & Gisele Bündchen Announce Long-Term Partnership

Retrieved on: 
Tuesday, June 29, 2021
Gisele Bündchen, Victoria's Secret, Gisele, FTX, Han Lue, FTX, Activists, Occupations, Activism

Tom will serve as an Ambassador for FTX and Gisele will take on the role of FTX's Environmental & Social Initiatives Advisor.

Key Points: 
  • Tom will serve as an Ambassador for FTX and Gisele will take on the role of FTX's Environmental & Social Initiatives Advisor.
  • As global icons, Tom Brady and Gisele Bndchen taking an equity stake and having an active role for the FTX group further solidifies FTX's status as the world's leading cryptocurrency exchange.
  • Tom will also work closely with Gisele and Sam on charitable aspects of the partnership to ensure each project has the greatest positive impact.
  • FTX, Gisele and Tom have also committed to providing an annual multi-million contribution to charity throughout the duration of the partnership.

FTX, Tom Brady & Gisele Bündchen Announce Long-Term Partnership

Retrieved on: 
Tuesday, June 29, 2021
Gisele Bündchen, Victoria's Secret, Gisele, FTX, Han Lue, FTX, Activists, Occupations, Activism

Tom will serve as an Ambassador for FTX and Gisele will take on the role of FTX's Environmental & Social Initiatives Advisor.

Key Points: 
  • Tom will serve as an Ambassador for FTX and Gisele will take on the role of FTX's Environmental & Social Initiatives Advisor.
  • As global icons, Tom Brady and Gisele Bndchen taking an equity stake and having an active role for the FTX group further solidifies FTX's status as the world's leading cryptocurrency exchange.
  • Tom will also work closely with Gisele and Sam on charitable aspects of the partnership to ensure each project has the greatest positive impact.
  • FTX, Gisele and Tom have also committed to providing an annual multi-million contribution to charity throughout the duration of the partnership.